TNF Pharmaceuticals Files 8-K Report
Ticker: QCLS · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1321834
| Field | Detail |
|---|---|
| Company | Tnf Pharmaceuticals, Inc. (QCLS) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, regulation-fd, exhibits
TL;DR
TNF Pharma filed an 8-K, likely with new docs. Check for material updates.
AI Summary
On March 6, 2025, TNF Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns a Regulation FD Disclosure and the inclusion of Financial Statements and Exhibits. No specific financial figures or material events beyond the filing itself were detailed in the provided text.
Why It Matters
This 8-K filing indicates that TNF Pharmaceuticals is providing updated information and exhibits to the SEC, which could contain material disclosures for investors.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing notification and does not contain specific material events or financial data that would indicate a high risk.
Key Players & Entities
- TNF Pharmaceuticals, Inc. (company) — Registrant
- MyMD Pharmaceuticals, Inc. (company) — Former company name
- Akers Biosciences, Inc. (company) — Former company name
- 001-36268 (company) — SEC File Number
- 22-2983783 (company) — IRS Employer Identification No.
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for a Regulation FD Disclosure and to include Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is TNF Pharmaceuticals, Inc.
In which state was TNF Pharmaceuticals, Inc. incorporated?
TNF Pharmaceuticals, Inc. was incorporated in Delaware.
What was the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is March 6, 2025.
What were some of the former names of TNF Pharmaceuticals, Inc.?
Some of the former names of TNF Pharmaceuticals, Inc. include MyMD Pharmaceuticals, Inc. and Akers Biosciences, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding TNF Pharmaceuticals, Inc. (QCLS).